Advertisement

Document › Details
Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel.
![]() |
Organisation | Genedata AG |
Group | Genedata (Group) | |
Organisation 2 | Sartorius AG | |
Group | Sartorius (Group) | |
![]() |
Product | Genedata Bioprocess™ software |
Product 2 | ambr® micro bioreactor system | |
![]() |
Index term | Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactos |
![]() |
Person | Pfannes, Othmar (Genedata 200406 CEO) |
Experimental data from ambr15 and ambr250 bioreactors are now directly captured and integrated into the Genedata Bioprocess workflow management system
Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of the Genedata Bioprocess® platform with the ambr® mini-bioreactor systems from Sartorius, a leading international pharmaceutical and laboratory equipment supplier. This enables the automatic import of raw instrument data into the Genedata Bioprocess platform, where the data can be processed and interpreted in the greater context of all data collected along the complete bioprocess development workflow. The integrations are instrument-specific, versioned, and maintained by Genedata.
ambr systems can now be easily plugged into the Genedata Bioprocess platform, which acts as a data backbone connecting all information from upstream, downstream, formulation, and analytics development units. This new integration capability leads to significant efficiency gains along the full bioprocess workflow.
Genedata Bioprocess is a first-in-class enterprise software solution that enables fully integrated workflow support for large-molecule development and CMC. As an integrated data backbone, it enables the cost-efficient development of next-generation manufacturing processes. Genedata Bioprocess is a modular system that supports the full workflow - from cell line development, upstream process development (USP), downstream process development (DSP), formulation development (FD) and analytical development (AD). The platform scales with highest data volumes and integrates all relevant experimental data, such as from bioreactors, purification instruments, or analytics devices. Genedata Bioprocess has been co-developed with major biopharmaceutical companies over the past five years.
“Our customers can now effortlessly connect Sartorius ambr systems to our Genedata Bioprocess platform. This enables a straight-forward setup of a fully integrated platform,” said Dr. Othmar Pfannes, CEO of Genedata. “The seamless integration between bioprocess instrumentation and Genedata Bioprocess simplifies day-to-day operations, saves time, and lowers our customers’ total cost of ownership. We look forward to expanding our established Ready-to-Run program to other instruments and technologies to further streamline bioprocess development operations.”
About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI from their R&D. Founded in 1997, Genedata is headquartered in Switzerland and has offices in Germany, the UK, Japan, and the US.
www.genedata.com
Follow Us on LinkedIn
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. All product and service names mentioned are the trademarks of their respective companies.
Record changed: 2018-10-24 |
Advertisement

More documents for Genedata (Group)
- [1] Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel....
- [2] Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC....
- [3] Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC....
- [4] Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel....
- [5] Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel....
- [6] Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel....
- [7] Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA....
- [8] Genedata AG. (7/10/18). "Press Release: MyBio Adopts Genedata for Improving Antibiotic Production Processes". Munich....
- [9] Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel....
- [10] Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top